Navigation Links
Deane F. Johnson Center Receives Ronald and Nancy Reagan Award
Date:5/28/2008

LOS ANGELES, May 28 /PRNewswire/ -- Dr. Jeffrey Cummings, Medical Director of The Deane F. Johnson Center for Neurotherapeutics at UCLA, received the prestigious Ronald and Nancy Reagan Research Award for the exceptional work he and his team devote themselves to, discovering new treatments and methods of care for patients with Alzheimers and other neurological disorders.

In his speech of acceptance at the annual National Alzheimer's Gala in Washington, Dr. Cummings applauded the tireless work of the center's co-founder Kate Edelman Johnson, who established the foundation in 1999 in memory of her late husband, former Time-Warner President Deane F. Johnson, who died from this dreadful disease.


'/>"/>
SOURCE Deane F. Johnson Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. The North Western Deanery of UKs National Health Service Selects eIQnetworks SecureVue for Comprehensive IT Assurance
2. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
3. VIDEO from Medialink and Johnson & Johnson: From Molecule to Medicine
4. Johnson & Johnson to Participate in Morgan Stanley Conference
5. Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program
6. UT Southwestern Medical Center receives grant from the Robert Wood Johnson Foundation
7. Johnson & Johnson to Webcast Annual Meeting of Shareholders
8. JOHNSONS(R) Launches New Online Campaign Tapping Glam Media to Reach Young Women
9. Johnson & Johnson to Participate in the 28th Annual Cowen & Company Health Care Conference
10. Johnson & Johnson to Participate in Lehman Brothers Eleventh Annual Global Healthcare Conference
11. Home Oxygen Community Applauds Senator Tim Johnson for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...er thrill when on an emotional rollercoaster, stud... News) -- Call it the fear factor meets the jubila...tators -- especially those who root for the winnin...a closely contested match and victory was in doubt..., Chew on that this Thanksgiving weekend as you,r...
(Date:11/26/2009)... Benton Communications announces a highl...tem for retailers struggling to make an economic r...er 26, 2009 -- Flu fears is the type of challenge ...ncy room, according to Dr. David Benton, business ...iness growth system – The Rfactor Intensive...
(Date:11/25/2009)...LLE,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPha...thecompanywillhosttwoinvestoreventsinDecember: ,...CT/10:00a.m.ET ,, Principalinvestigatorswilld...apsedand/orrefractorymultiplemyeloma,asfeaturedatt...gandExpositioninNewOrleans,LA.Theteleconferencewil...
(Date:11/25/2009)...PRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticle...ugEvaluationandResearch,titled"ADifficultBalance-P...v.26,2009issueofTheNewEnglandJournalofMedicine. ,...90824/FDALOGO ) ,, Inthearticle,Woodcockdiscuss...icationforthosewhoneeditandmanagingtherisksposedby...
(Date:11/25/2009)...vivors of testicular cancer who were treated with ...effects, including neurological side effects and R...ed with chemotherapy, according to a new study pub...ational Cancer Institute . , Marianne Brydy, M.D...sity Hospital, in Bergen, Norway, and colleagues c...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
... Gary Bell named President... Alpharetta, GA (PRWEB) September 29, 2008... (JH), an Atlanta based healthcare staffing and te...m,s significant years of business management, heal...
... Morrison Management Speci...Wellness Program to hundreds of locations. , ...er 29, 2008 - PureWellness, Inc, a leading provide...utrition services to hospitals and senior living c...
... Viruses dramatically increase cellular metabolism...new way to block these metabolic changes and inhib... today in the journal Nature Biotechnology . , ...own nutrients into complex molecules (e.g. DNA). A...
... The National Institutes o... SBIR grant to develop a red VCSEL array assembly ...systems. Vixar is developing the new technology f...et. , (PRWEB) September 2...
...CSON, Ariz., Sept. 27 The Paul D.,Wellstone Muscu...ducation,(MD-CARE) Amendments of 2008 received fin...esident Bush, who is expected to sign it., The ap...orms of muscular dystrophy., Dr. R. Rodney Howell...
... The Vodafone Foundation-U...Co., Inc., the Kessler Family Foundation and the A... at Clinton Global Initiative , ... from the http://www.unfoundation.org/global-issue...
Other Medicine News:Health News:Jackson Healthcare Forms New Operating Company to Acquire and Manage Hospitals 2Health News:Nation's Leading Food Services Provider Chooses PureWellness to Drive Corporate Wellness Program 2Health News:Existing anti-obesity drugs may be effective against flu, hepatitis and HIV 2Health News:Existing anti-obesity drugs may be effective against flu, hepatitis and HIV 3Health News:Existing anti-obesity drugs may be effective against flu, hepatitis and HIV 4Health News:NIH Awards a Phase I Small Business Innovative Research Grant on "Novel Laser Scanning Technology for Computed Radiography" to VIXAR and iCRco 2Health News:Updated MD-CARE Act Receives Final Congressional Approval 2Health News:$9 Million Committed to Bolster Worldwide Measles Initiative 2Health News:$9 Million Committed to Bolster Worldwide Measles Initiative 3
(Date:11/25/2009)... DELFT,TheNetherlandsandJOHANNESBURG,November25/PR...andPyxisDiscoveryannouncedtoday,thattheyhavesigned...es,services. , Pyxis,sworldclasscomputational...thiThemba,sservicedivisiontoprovidemedicinaland,sy...Pyxis,internationalclientnetwork.iThembaPharmaceu...
(Date:11/24/2009)... BETHESDA,Md.,Nov.24/PRNewswire-Asia/--ChindexInte...independentAmericanproviderofWestern,healthcarepro...,announcedthattheCompanywillattendthe21stAnnualPip...December1-2,2009,atthe,NewYorkPalaceHotel. , ...onTuesday,December1,2009,andholdone-on-onemeeting...
(Date:11/24/2009)... MADISON,N.J.,Nov.24/PRNewswire-FirstCall/--QuestD...ngproviderofdiagnostictesting,informationandservic...lPiperJaffrayHealthcareConferenceinNewYorkCity.The...at9:30a.m.EasternTime. ,, Duringtheconference,t...thtoapproximate3%,operatingincometoexceed18%ofreve...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Chindex International to Present at Piper Jaffray Health Care Conference 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Cempra Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 6531 1Cutting greenhouse pollutants could directly save millions of lives worldwide 62111 1Cutting greenhouse pollutants could directly save millions of lives worldwide 62111 2Cutting greenhouse pollutants could directly save millions of lives worldwide 62111 3ER Visits for Elderly Rise During Thanksgiving 62108 1ER Visits for Elderly Rise During Thanksgiving 62108 2ER Visits for Elderly Rise During Thanksgiving 62108 3
...esults from a 24-week multi-center, randomized, op... at ADA 2008, SAN FRANCISCO, June 9 Amylin Ph...d data showing that the use of mealtime,SYMLIN(R) ... therapy for 24,weeks resulted in more patients ac...se control without weight gain or hypoglycemia com...
...OUNTAIN VIEW, Calif., June 9 Alexza,Pharmaceutica...ary results,from its Phase 2a proof-of-concept cli...n patients with panic disorder. The study did not ...ect of AZ-002 on the incidence of a,doxapram-induc...ration of a,doxapram-induced panic attack, both as...
Other Medicine Technology:Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 2Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 3Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 4Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 5Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 2Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 3Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 4
Ascent Primary Knee System
...bilized knee has an advanced design which provides...surfacing and inset patellas. Precision machined c...fit with tibial articular surface and patella to r...rovide easy intraoperative change of sizes. Increa...
Proven Cruciate Retaining Knee System
Foundation Knee CR System
Medicine Products: